It has been well established that serum complement levels tend to decrease during experimental anaphylactic shock and serum sickness type hypersensitivity (1-6). In both anaphylactic shock and experimental "serum sickness" there has been a close correlation between the removal of antigen by antibody with the formation of complexes and a fall in the titer of serum complement (5-6). The fall in serum complement presumably is due to the well known capacity of antigen-antibody complexes to bind complement. Whether the tissue lesions of hypersensitivity are mediated by the activation of complement by complexes or whether the binding of complement is merely an unnecessary by-product of the antigen-antibody interaction determining the development of the lesions, is unknown.
(Received for publication, June 16, 1961) It has been well established that serum complement levels tend to decrease during experimental anaphylactic shock and serum sickness type hypersensitivity (1) (2) (3) (4) (5) (6) . In both anaphylactic shock and experimental "serum sickness" there has been a close correlation between the removal of antigen by antibody with the formation of complexes and a fall in the titer of serum complement (5) (6) . The fall in serum complement presumably is due to the well known capacity of antigen-antibody complexes to bind complement. Whether the tissue lesions of hypersensitivity are mediated by the activation of complement by complexes or whether the binding of complement is merely an unnecessary by-product of the antigen-antibody interaction determining the development of the lesions, is unknown.
The recent experiments of Osler and his coworkers (7) (8) implicate complement in the mediation of passive cutaneous anaphylaxis. The works of Levine (9), Lepow, Ratnoff, and Pillerner (10) , and Becket (11, 12) suggest that the first component of complement consists of a proesterase which can be activated by antigen-antibody complexes. It is conceivable that the tissue lesions of hypersensitivity might be enzymatically induced through the action of complement.
A preliminary study was undertaken to determine the changes in total complement activity in the serum of animals developing accelerated "serum sickness." It was found that a reduction of total complement activity in these animals almost always coincided with the time of antigen clearance. Subsequently, attempts were made to lower complement activity in the serum by the intravenous administration of heterologous immune precipitates or immune soluble complexes to determine whether a reduction in complement activity would m o d i f y t h e incidence of allergic lesions in " s e r u m sickness." T h e accele r a t e d f o r m of s e r u m sickness was e m p l o y e d to lessen t h e period of i n t r a v e n o u s a d m i n i s t r a t i o n of heterologous i m m u n e complexes.
Materials and Methods
Experimental Animals.--Male albino rabbits weighing 2 to 3 kg were used in all experiments. Alum-precipitated crystallized bovine serum albumin (BSA) was prepared as described by Kabat and Mayer (13) . Rabbits were sensitized by 8 dally intravenous injections of 4.2 ml alum-precipitated BSA containing 1 mg of protein nitrogen. They were then allowed to rest for 3 days after which they were skin-tested with 1 mg BSA protein in 0.2 ml volume. 24 hours later skin tests were read and the animals were given a 0.5 gm BSA intravenously for production of accelerated "serum sickness." Most of the animals eliminated the BSA in 3 to 7 days. The day of elimination was determined by performing daily antigen capillary tests as described previously (14) . Blood samples were taken at appropriate intervals in order to determine the level of total complement activity. The animals were usually sacrificed 1 day after the antigen became negative at a time when the highest incidence of lesions would be expected (15) . The tissues were prepared for histologic study in the usual manner.
Preparation of Bovine Plasma Gamma Globulin (BGG)
Antigen-Antibody Insoluble Complexes.--BGG antiserum was obtained from a large series of rabbits receiving weekly subcutaneous injections of 20 mg of this antigen contained in 1 ml Freund's complete adjuvant mixture. At appropriate intervals during immunization, blood was obtained from the marginal ear vein and utilized to determine the approximate amount of circulating antibody. Animals with sera containing high concentrations of antibody were bled by cardiac puncture; the sera were pooled and stored at -15°C until used. The average antibody concentration of these pooled sera ranged from 0.6 to 0.7 mg antibody nitrogen (AbN) per ml. Immune precipitates were prepared in antibody excess. The antigen and antiserum were mixed at room temperature and allowed to stand at 37 ° for 30 minutes and at 3°C overnight. The resulting precipitate was washed once with cold saline, finely dispersed by use of the Waring blender, and suspended in isotonic saline so that an aliquot of precipitate containing 20 mg of AbN occupied a volume of 50 ml.
Antigen-Antibody Soluble Complexes.--Immune soluble complexes were prepared by mixing bovine plasma gamma globulin and rabbit anti-bovine plasma gamma globulin at equivalence. The mixture was allowed to set at room temperature for 10 minutes and then centrifuged for 5 to 10 minutes at 1800 l~P~. The precipitate was washed twice with cold physiological saline. To this precipitate was added 9 X equivalence of bovine plasma gamma globulin in isotonic saline so that 10 ml of this new mixture contained 20 mg ABN. Even after many hours of shaking precipitates made with bovine gamma globulin and its corresponding antibody failed to dissolve in excess antigen. Accordingly, this mixture was treated with sufficient INNaOH to dissolve the precipitate. The resulting pH of this mixture was about 11.5.5 to 10 minutes later, enough INHCI was added to adjust the pH to approximately 7.5. The entire procedure was carried out at room temperature. These soluble complexes were prepared just before usage because reprecipitation consistently occurred upon standing.
Titration of Hemolytic Activity of Whole Complement.--Blood was obtained from individual rabbits from the marginal ear vein. It was collected in chilled tubes, placed in cold water bath at 0°C, and allowed to clot for 4 to 8 hours. The blood was centrifuged at 3°C and the serum so obtained was stored at -60°C. All blood samples from a given rabbit were assayed for hemolytic activity on the same day. Hemolytic activity was determined using only slight modification of the method described by Kabat and Mayer (13) .
A sample of rabbit serum obtained from the experimental animals was thawed just before determining its hemolytic activity. The temperature of the serum was never allowed to get above 3°C. It was again frozen and stored at --60°C after use to allow additional determinations. The serum was diluted with cold isotonic veronal buffer to yield a concentration suitable for estimation of CHs0 units. Preliminary experiments revealed that the rabbit complement hemolysis curve differs from the guinea pig curve in that an end point is not reached even after several hours of incubation at 37°C. An incubation time of 3 hours was arbitrarily chosen for these experiments. The percentage of hemolysis was determined for each sample and the CH60 units were calculated by the use of the conversion factors derived from the Vou Krogh equation with a value of 0.2 for the exponent 1/n. A complete curve of hemolysis was constructed on occasional sera in order to calculate 1/n experimentally. A value of 0.2 ± 10 per cent was found with only occasional deviations.
Occasional sera with low complement titers were examined for their anti-complementary effect. Such sera were heated at 56 ° for 30 minutes, added to active fresh rabbit serum, and the hemolytic activity of such mixture was compared with the fresh rabbit serum activity alone. In no instance was the heated serum anti-complementary.
Several sera of varying hemolytic activity were examined for the presence of naturally occurring hemolysins by using unsensitized sheep cells for the titration of hemolytic activity. None of the animals tested was found to have hemolytic antibodies to the sheep red cells employed. Several rabbits developing serum sickness type lesions were examined for the presence of heterophile antibodies with negative results.
EXPE]~ rM~.NTAL RESULTS

I. The Relationship between Serum Complement A trinity, Antigen Elimination, and the Development of Allergic Lesions in Accelerated "Serum Sickness" in Rabbits.--
Forty-three rabbits in five separate experiments were sensitized with alum-precipitated BSA and then given 0. 5 gin of BSA for the proeuction of accelerated "serum sickness." The animals were bled on the day of the large injection of antigen and for several days prior to this injection. Subsequently, they were bled daily and their sera tested for the presence of antigen. The hemolytic complement activity of the serum samples was determined at a later date. The results of these determinations are summarized in Table I , where it is apparent that a decrease in complement occurred in 42 of 43 animals. In most instances, this reduction occurred simultaneously with the complete clearance of antigen by antibody. This temporal relationship between antigen clearance and reduction in complement levels is presented diagrammatically in Fig. 1 .
Although there was a very dose time relationship between the drop in complement and antigen clearance, it is apparent from Table I that the degree of complement drop cannot be directly correlated with the presence or absence of allergic lesions.
II. The Effect of tke Intravenous Administration of Heterologous Precipitates (BGG System) on Complement Levels and Incidence of Lesions in Rabbits witk Accelerated "Serum Sickness."--
Preliminary experiments were made to determine the capacity of antigen-antibody precipitates to lower hemolytic complement levels. For this purpose, a series of normal rabbits were injected with varying dosages of immune precipitates. It was found that a dosage of value. However, after this time the complement levels began to rise and at 24 hours they were 60 to 85 per cent of their normal level. Apparently, the intravenous administration of large amounts of immune precipitates did not suffice to keep the complement at appreciablp low levels for more than a few hours.
The effect of intravenous injections of precipitated immune complexes on the total hemolytic complement levels during accelerated "serum sickness" is shown in Fig. 3 . It will be recalled that the in vivo antigen-antibody reaction producing "serum sickness" in itself causes a marked diminution of complement levels.
It was found that the complement levels of sensitized animals were further reduced by the injection of immune precipitates. As in the normal animals, the effects lasted for less than 8 hours. Attempts were made to produce a sustained lowering of complement levels by more frequent injections of immune precipitates. I t was found that the animals could not withstand treatment by precipitates at the dosage given more frequently than once every 24 hours. In order to determine whether the brief periods of reduced complement activity brought about by daily injection of immune precipitates could modify the incidence of allergic lesions, a series of 11 animals were treated with B G G immune precipitates beginning 48 hours after the large dose of BSA and continuing for 3 days. 12 other animals undergoing accelerated "serum sickness" but receiving no treatment were used as controls.
Bleedings were performed on all animals just prior to the injection of immune precipitates and 8, 12, and 16 hours thereafter. Antigen clearance as well as hemolytic complement titers were followed. Each animal was killed 1 day after the antigen had disappeared from the circulation.
In Table I I are recorded, together with the observations on complement titers and antigen clearance, the incidence of the two major lesions (15) found in hypersensitivity of the serum sickness type. Since in the present experiment observations were made only at 8, 12, and 16 hours after injection of immune precipitates, the prompt reduction in hemolytic complement titers following BGG precipitates was not encountered and no difference in the complement titers was observed in the two groups of animals.
Although the incidence of proliferative glomerulonephritis was found to be the same in both the treated and untreated groups, a significant difference was observed in the incidence of arterial lesions between the control animals and those receiving BGG antigen-antibody precipitates. Acute arteritis was observed either in the heart or lungs of 92 per cent (11/12) of the control animals and in only 27 per cent (3/11) of the injected animals. It is of interest that the arterial lesions that were present in the treated animals were observed only after numerous sections of the heart and lungs were examined and these lesions were characterized by slight intimal or adventitia proliferation. Frank arterial necrosis which was so common in the control animals was not seen in the treated group.
I l L The effect of the Intravenous Administration of tteterologous Soluble Immune Complexes (BGG System) on Complement Levels and Incidence of Lesions in Rabbits with Accelerated Serum Sickness.--Since it was found impossible to
give repeated frequent injections of immune precipitates in an attempt to produce sustained reduced levels of hemolytic complement activity in the serum, other methods of partial "decomplementation" were sought. It was found that one could inject soluble immune complexes repeatedly without adverse effect on the rabbits. The effect of soluble complexes on hemolytic complement level was found to be variable even when prepared under the same conditions and in the same degree of antigen excess. At times, the soluble complexes were found to have no apparent effect on complement levels while at other times, they produced a noticeable reduction in complement titer when injected intravenously into normal rabbits. The cause of this inconstant behavior is not clear but similiar difficulties have been encountered in studies on the anaphylactogenic properties of soluble complexes (16, 17) .
In order to study the effect of heterologous immune complexes on the development of allergic lesions and the level of hemolytic complement activity in the serum, 11 rabbits undergoing accelerated "serum sickness" were injected with 10 ml of BGG immune soluble complexes (20 nag AbN) at 24 hours after the large dose of BSA. This treatment was repeated every 4 hours for the first 24 hours of administration and every 8 hours thereafter until the animal eliminated his BSA antigen. 11 other animals undergoing accelerated serum sickness were injected at the same time intervals with 10 ml of a protein solution containing BSA and rabbit serum to serve as control animals. This protein solution had been treated with alkali and acid in a manner similar to that used in preparation of immune soluble complexes. A third group of 3 normal animals was injected with immune soluble complexes at the same time intervals as the experimental animals. 2 of the 3 normal animMs and 4 each of the two groups of sensitized animals were bled prior to each injection in order to determine the hemolytic complement levels. The sensitized animals were killed 24 hours after the antigen had disappeared from the drculation. The normal rabbits were sacrificed with the last sensitized animals.
In Table IH are recorded the complement levels on these selected sensitized animals and observations on antigen clearance and incidence of the two major lesions of "serum sickness" in the two groups of sensitized animals. Although there was a drop in complement titers in both groups of animals as they developed serum sickness, it is apparent that there was no observable difference in the complement level between the two groups. This indicates that the injection of soluble complexes had not affected a reduction in complement levels. This finding was borne out in the observation that in the normal rabbits treated with these same soluble complexes, the complement levels remained elevated despite frequent treatment with the soluble immune complexes.
Although the complement levels were unaffected by the treatment with soluble complexes, apparently, the incidence of necrotizing arteritis was markedly reduced in the sensitized animals so treated. The incidence of glomerulonephritis was the same in the two groups of animals. It is of interest that each of the 3 normal animals receiving multiple injections of soluble complexes exhibited mild proliferative changes in the glomeruli similar to what has been described in Table III as trace glomerulonephritis.
DISCUSSION
The present data on hemolytic whole complement titers during serum sickness hilly support the finding of Janeway and his coworkers indicating a reduction in complement titers at the time of development of allergic lesions. Correlation of the time of maximal reduction of complement activity with the time of occurrence of complete antigen elimination supports the hypothesis that the reduction of complement titer is due to the immune phase of antigen elimination. In only 1 out of 43 animals was there a disagreement between antigen clearance and the lowest observed complement titer. In view of the numerous factors contributing to the supply and demand for complement during "serum sickness" it is not Surprising that the severity of the allergic lesions could not be correlated with the magnitude of the reduction in complement activity.
Although numerous attempts were made by modification of dosage, time intervals, and number of injections to produce a sustained lowering of complement titer it was found that the rabbits could not tolerate the large volumes of precipitates required to accomplish this state.
The procedure finally adopted consisted of a single daily injection of finely dispersed heterologous immune precipitates. Although this produced a marked reduction in complement level, the effect was quite temporary and levels of complement activity comparable to those noted in untreated animals were present during most of the time of the development of accelerated serum sickness.
Although heterologous immune precipitates had little effect on complement levels, they profoundly influenced the development of allergic arterial lesions in animals developing accelerated serum sickness. It seemed unlikely that the failure of the development of necrotizing arteritis was due to the temporary drop in hemolytic complement levels. This belief was supported by subsequent work on the effect of heterologous soluble immune complexes on the development of allergic arteritis. Although soluble complexes prepared as herein described failed to produce the slightest observable alteration in total hemolytic complement activity, they did effect a marked reduction in the development of allergic arteritis. Although these experiments do not clarify the mechanism by which allergic arteritis was diminished, they do re-emphasize the extreme caution one must employ in correlating the level of whole complement hemolytic activity and allergic response.
The failure of injections of immune soluble or insoluble complexes to influence the development of glomerulonephritis while markedly suppressing the incidence of arterial lesions is noteworthy. In view of the focal nature of the arterial lesion, one must question whether the marked statistical difference between the incidence of arteritis in the treated and untreated animals was more apparent than real. That this is unlikely was established by the careful examination of numerous sections of the heart and lungs of these animals. Furthermore, not only was there a difference in the number of animals displaying the lesions of arteritis, but there was also such a decided difference in the severity of the lesions that did occur that one could easily determine the controls from the sensitized animals that had received immune complexes.
One wonders whether the different effects of the immune complexes on the development of the glomerular and arterial lesions is purely a quantitative one (18) or whether this differing effect is due to fundamental differences in the pathogenesis of these two lesions. Although these two lesions are considered to have a common etiological mechanism the possibility exists that they might have somewhat different pathologenitic mechanisms. Recent experiments show that under certain conditions, each of these lesions can be produced independently of one another (18, 19) .
SUMMARY
Total serum hemolytic complement activity is consistently reduced in animals undergoing accelerated "serum sickness". The time of maximum reduction in complement titer invariably coincides with the time of complete antigen disappearance. This temporal relationship supports the belief that the reduction in complement titer is brought about by in ~,ivo antigen-antibody combination.
The intravenous administration of a single daily large dose of BGGprecipitated complexes produces a marked but temporary reduction in total complement hemolytic activity. On the other hand, multiple injections of soluble BGG immune complexes prepared in antigen excess failed to even temporarily alter complement titers. Animals undergoing the development of accelerated "serum sickness" treated by either type immune complex showed a significantly reduced incidence of arterial lesions. Apparently, this inhibiting effect on the development of arterial lesions was independent of variations in total complement hemolytic activity.
